AzTrials
AzTrials

Vitamin C AnemiaNCT05975125

The Effect of Vitamin C for Iron Supplementation During Pregnancy with Risk of Anemia

A study testing Vitamin C 500 MG Oral Tablet in people with Vitamin C Anemia and Pregnancy Anemia, run by Department of Medical Services Ministry of Public Health of Thailand at 1 site in Thailand.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Anemia is a common problem during pregnancy. Most studies have demonstrated that anemia during pregnancy have adverse effects on their pregnancy outcome, which is important and should pay attention to prevent and solve such problems. The most common cause of anemia is iron deficiency. Read more about this study

Who is it for?
Any age, women onlyHealthy volunteers can take part
Conditions the study is for
Vitamin C Anemia, Pregnancy Anemia
What is being tested?
Vitamin C 500 MG Oral Tablet
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteThailand
Study dates
28 Jun 2023to 27 Jun 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Pregnant woman Antenatal care at Rajavithi Hospital
  • Singleton pregnancy
  • Provide inform consent with both patient and her husband
  • Gestational age between 14-28 weeks
  • Risk of anemia during pregnancy, including more than 2 pregnancies, teenage pregnancy, advanced maternal age over 35 years old, mothers with body mass index below 18.
  • 5. Pregnant women with hemoglobin greater than 10.5 g/dL, hematocrit greater than 32 % in the first antenatal blood results. 6. Giving birth at Rajavithi Hospital 7. Can communicate and understand Thai language very well

Who cannot join

  • Receive vitamin C supplements during the program
  • HIV infection
  • Iron deficiency anemia or blood diseases such as thalassemia
  • Gastrointestinal bleeding
  • Antenatal hemorrhage
  • Allergic to vitamin C or iron
Show all 11Show fewer
  • Congenital diseases including kidney disease, liver disease, joint disease and bleeding disorders.
  • Symptoms that indicate infection, such as fever, sore throat, sputum, diarrhea, loose stools, etc.
  • History of iron intake within the past 3 months
  • Received blood components within the past 3 months or while participating in a research project
  • Giving birth during the drug trial

Trial locations and contacts

1 site in 1 country.

Thailand1 site
  • Rajavithi

    Phaya Thai, ratchathewi, 10400

Other trials in Thailand

About this study

Anemia is a common problem during pregnancy. Most studies have demonstrated that anemia during pregnancy have adverse effects on their pregnancy outcome, which is important and should pay attention to prevent and solve such problems. The most common cause of anemia is iron deficiency. Several studies reveal that Vitamin C promotes iron absorption. In this study we will compare between Vitamin C with iron supplement and iron supplement alone in prevention of anemia in pregnancy.

Read the detailed description

Anemia in pregnancy associated with Diabetes during pregnancy 15.9 % Fetal abnormalities in blood oxygen causing fetal non reassuring 9.4% , Preterm delivery 8.2 %, Amniotic fluid insufficiency 1.95 %, 10.6 % of infants had complications after birth, 9.7 % of infants were hospitalized in intensive care units with birth weight less than 2,500 grams . (Low birth weight) 4.9%, anemia also significantly increased the likelihood of blood transfusion during pregnancy.

There is also a study on the risk of developing anemia such as more than 2 pregnancies, Teenage pregnancy, Advanced maternal age more than 35 years old, Mothers with a body mass index below 18 are at increased risk of developing anemia. The most common cause of anemia during pregnancy is iron deficiency. This may be caused by receiving the element. not enough iron or there is a loss of iron from blood loss which is important and should pay attention to prevent and solve such problems. Which Vitamin C promotes iron absorption. Vitamin C combined with iron has been studied. It clearly increases hemoglobin and hematocrit. And is safe for pregnant women and babies. There is also no evidence that vitamin C is a carcinogen, or a cause of birth defects or toxicity. However, there are no studies related to the combination of vitamin C and iron in pregnant women at risk of anemia. To solve the problem and prevent the consequences of the above mentioned anemia. In this study we will compare between Vitamin C with iron supplement and iron supplement alone in prevention of anemia in pregnancy.

Being tested
Vitamin C 500 MG Oral Tablet
Keywords
Vitamin C, Pregnancy with anemia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Vitamin C 500 MG Oral TabletDrug

    compare between Vitamin C with iron supplement and iron supplement alone in prevention of anemia in pregnancy.

Study groups in NCT05975125
Study groupRoleWhat they receive
Iron supplement with Vitamin CExperimentalVitamin C with Iron supplement Drug: Vitamin C 500mg Triferdine(Component: Iodine 0.15 mg, Iron 60.81 mg, Folic acid 0.4 mg)
Receives: Drug: Vitamin C 500 MG Oral Tablet
Iron supplementation aloneNo interventionIron supplement alone Drug: Triferdine Component: Iodine 0.15 mg, Iron 60.81 mg, Folic acid 0.4 mg

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. To compare hemoglobin and hematocrit levels

    To compare hemoglobin and hematocrit levels between groups receiving vitamin C with iron and the group receiving only iron supplement

    Measured: 2 months after intervention

Secondary outcomes (3)
  1. maternal and fetal pregnancy outcomes

    To compare maternal and fetal pregnancy outcomes such as postpartum haemorrhage, blood transfusion after birth, birth body weight, gestational age at childbirth, the health of the baby after birth, etc., among the groups that received vitamin C and iron intake compare with the group that received only iron supplement alone.

    Measured: after intervention until delivery

  2. ratio of vitamin C

    To study the ratio of vitamin C and iron supplement in prevention of anemia in pregnancy.

    Measured: 2 months after intervention

  3. side effects after receiving vitamin C

    To study the side effects after receiving vitamin C during pregnancy.

    Measured: 2 months after intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Aug 2023
  2. Study start28 Jun 2023
  3. Primary completion27 Jun 2024
  4. Study completion27 Jun 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05975125
Sponsor's protocol ID
118/2566
Status last verified
Jun 2023
First submitted
27 Jul 2023
Last updated
14 Nov 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Vitamin C 500 MG Oral Tablet in people with Vitamin C Anemia and Pregnancy Anemia, run by Department of Medical Services Ministry of Public Health of Thailand at 1 site in Thailand.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To compare hemoglobin and hematocrit levels (time frame: 2 months after intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in